Netcare’s 2020 earnings plummet due to Covid-19

Group estimates it has lost about R3.7bn in revenue due to the coronavirus pandemic

Life Healthcare cautiously optimistic even as it eyes second-wave threat in SA

The group estimates the first wave of the pandemic cost its Southern African operations R2.3bn in lost revenue, but it’s now better prepared

Moderna says its vaccine is nearly 95% effective

Moderna shares surge as much as 15% as it  becomes the second US drugmaker to report results that far exceed expectations

Mediclinic still not seeing a Covid-19 rebound in SA

The private hospital group’s operations in Switzerland and the Middle East have bounced back

Herbalife Nutrition celebrates 25 years in SA

SPONSORED | Herbalife Nutrition products are designed to help health enthusiasts achieve their goals

Discovery dealt a blow by order to stop cheap health cover

Industry peers block expansion of low-cost benefit options; no new members to be enrolled

WATCH: How Dis-Chem is mulling further acquisitions

Dis-Chem CFO Rui Morais talks to Business Day TV about the group’s annual financial results

NHI vs medical schemes: worlds apart or partners for the future?

SPONSORED | Business Day Dialogue in partnership with ASI on the future of health care in SA

Biogen surges 47% on FDA support for Alzheimer’s drug

In an unusual move, the US Food and Drug Administration combines its reviewers’ findings with Biogen’s in one document ahead of meeting on the drug

WATCH: How Aspen secured a Covid-19 vaccine deal

Aspen Pharmacare CEO Stephen Saad talks to Business Day TV about its preliminary agreement with Johnson & Johnson

Aspen bags Covid-19 vaccine deal with Johnson & Johnson

Agreement will enable drugmaker to use spare manufacturing capacity and bring down overhead costs, says CEO

Understanding the expected impact on Covid-related deaths and illnesses

SPONSORED | The impact on future income disability rates, may be influenced by the state of the economy

Brimstone to sell out of Life Healthcare after 15 years

Investment company says sale of stake in hospitals group will raise R1.35bn which will be used to reduce debt in an uncertain economy

Opioid maker Purdue reaches $8bn settlement to end probe

Purdue formally admitted to criminal conduct related to distribution of its painkillers and agreed to pay $225m to resolve US justice department investigations

Roche pushes antigen tests for second Covid-19 wave

Diagnostics boom helps the Swiss drug company stick to its 2020 targets

Mediclinic reports Covid-19 profit hit, but patient numbers are recovering

Covid-19 weighed on the group in the six months to end-September, but Mediclinic has seen a rebound in trading since May


Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.